Delfi Krishna: How to Compete in the Gene Therapy Market
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
Cell and gene therapies represent an exciting and complex new treatment type, with the potential to treat a vast range of indications.
With this 2023 round of funding, we will have funded 19 projects since the Spring of 2019.
Gaye Bok, an MIT Sloan alum, heads up the Mass General Brigham’s (MGB) $30M AI and Digital Innovation Venture Fund (AIDIF).
MIT Sloan Alum Reflects on the Effect of Healthcare Lab on Her Career
SilverCloud by Amwell is one of the organizations taking part in the MIT Sloan HSI Lab for Population Health’s research on workplace wellness.
13 Student Teams Presented Results of their Real-world Projects
Data management practices used to evaluate pandemic data and the deleterious effect of antiquated and varied state reporting methods.
Discussion of the October 2022 HSI Convening
This convening introduced the HSI Lab on Employee Population Health
MIT Sloan students bring a variety of experiences when they matriculate at the Institute.